Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil in Duchenne Muscular Dystrophy
NCT05195775Phase 3Completed
- Sponsor
- University of Florida
- Start
- Dec 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tadalafil in Duchenne muscular dystrophy (DMD), sponsored by University of Florida. Started Dec 2021; status: completed.
02
Drugs
tadalafil
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on NCT05195775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195775.